4Kondrup J, Rasmussen HH,Hamberg O,et al.Nutritional risk screening (NRSv2002) : A new method based on an analysis of controlled clinical trials [ J ].Clin Nutr, 2003,22 ( 3 ): 321-336.
5Munshi A,Pandey MB,Durga T,et al.Weight loss during radiotherapy for head and neck malignancies:What factors impact it ? [ J ].Nutr Cancer, 2003,47 (2) : 136-140.
6Aslani A,Smith RC,Allen BJ,et al.The predictive value of body protein for chemotherapy-induced toxicity [ J ].Cancer, 2000, 88(4) :796-803.
7Mick R,Vokes EE,Weichselbum RR,et al.Prognostic factors in advanced head and neck cancer patients undergoing mutimodality therapy[J].Otolaryngol Head Neck Surg, 1991,105( 1 ) :62-73.
8Jager-Wittenaar H,Dijkstra PU,Vissink A,et al.Variation in repeated mouth-opening measurements in head and neck cancer patients with and without trismus [J].Int J Oral Maxillofac Surg, 2009,38( 1 ) : 26-30.
9Lee H, Havrilla C, Bravo V, et al.Effect of oral nutritional supple-mentation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma [J].Support Care Cancer, 2008,16 (3) : 285-289.
10Meiners S, Eickelberg O. What shall we do with the damaged proteins in lung diseases? Ask the proteasome! [J]. Eur Respir J, 2012[Epub ahead of print].
